Ranibizumab injection and laser photocoagulation to treat type 1 retinopathy of prematurity after 40 weeks post menstrual age: a retrospective case series study

Ranibizumab injection and laser photocoagulation to treat type 1 retinopathy of prematurity after 40 weeks post menstrual age: a retrospective case series study

Abstract Background Type 1 retinopathy of prematurity (ROP) is occasionally observed in preterm infants after the postmenstrual age (PMA) of 40 weeks; however, evidence-based treatment guidelines are largely lacking. In this study, we report the clinical characteristics of preterm infants with type...

Full description

Bibliographic Details
Main Authors: Jiao Lyu, Qi Zhang, Chunli Chen, Yu Xu, Xunda Ji, Peiquan Zhao
Format: Article
Language:English
Published: BMC 2019-02-01
Series:BMC Ophthalmology
Subjects:
Retinopathy of prematurity
Older ROP
Treatment
Vascular endothelial growth factor
Laser
Postmenstrual age
Online Access:http://link.springer.com/article/10.1186/s12886-019-1067-4

Internet

http://link.springer.com/article/10.1186/s12886-019-1067-4

Similar Items